Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 1
1921 1
1941 1
1951 2
1952 1
1954 1
1955 1
1964 1
1965 4
1969 1
1970 1
1971 3
1972 2
1973 1
1974 1
1975 1
1976 3
1977 8
1978 2
1979 6
1980 7
1981 3
1982 3
1983 2
1984 2
1986 2
1987 2
1988 2
1989 1
1990 1
1991 3
1992 8
1993 6
1994 14
1995 9
1996 7
1997 8
1998 6
1999 6
2000 7
2001 10
2002 6
2003 14
2004 11
2005 9
2006 17
2007 18
2008 19
2009 20
2010 17
2011 31
2012 35
2013 29
2014 37
2015 38
2016 48
2017 35
2018 35
2019 41
2020 60
2021 44
Text availability
Article attribute
Article type
Publication date

Search Results

647 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Ntim-Amo
Page 1
Primary biliary cholangitis.
Lleo A, Wang GQ, Gershwin ME, Hirschfield GM. Lleo A, et al. Lancet. 2020 Dec 12;396(10266):1915-1926. doi: 10.1016/S0140-6736(20)31607-X. Lancet. 2020. PMID: 33308474 Review.
Sorafenib: A Review in Hepatocellular Carcinoma.
Keating GM. Keating GM. Target Oncol. 2017 Apr;12(2):243-253. doi: 10.1007/s11523-017-0484-7. Target Oncol. 2017. PMID: 28299600 Review.
Its approval was based on the results of the pivotal SHARP and Sorafenib Asia-Pacific (AP) trials in Child-Pugh (CP) class A patients with advanced HCC, which showed significantly longer median overall survival (OS) and time to radiological progression (TTP) with sorafenib 400 mg …
Its approval was based on the results of the pivotal SHARP and Sorafenib Asia-Pacific (AP) trials in Child-Pugh (CP) class A patients with a …
Prevention of food allergy.
du Toit G, Tsakok T, Lack S, Lack G. du Toit G, et al. J Allergy Clin Immunol. 2016 Apr;137(4):998-1010. doi: 10.1016/j.jaci.2016.02.005. J Allergy Clin Immunol. 2016. PMID: 27059727 Free article. Review.
Deadly Single Dose Agents.
Euwema MS, Swanson TJ. Euwema MS, et al. 2021 Aug 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. 2021 Aug 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 28722879 Free Books & Documents. Review.
Although the basics of evaluating and treating most unknown ingestants are well known, many overdoses require very specific treatment if the patient is to have any chance of survival. Countless studies have been published supporting Dr. Gideon Koren's 1993 landmark article …
Although the basics of evaluating and treating most unknown ingestants are well known, many overdoses require very specific treatment if the …
Reply.
Perkin MR, Bahnson HT, Lack G; EAT Study Team. Perkin MR, et al. J Allergy Clin Immunol. 2020 Apr;145(4):1305-1306. doi: 10.1016/j.jaci.2020.01.015. Epub 2020 Feb 25. J Allergy Clin Immunol. 2020. PMID: 32111420 No abstract available.
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.
Marrero JA, Kudo M, Venook AP, Ye SL, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JH, de Guevara LL, Papandreou C, Takayama T, Sanyal AJ, Yoon SK, Nakajima K, Lehr R, Heldner S, Lencioni R. Marrero JA, et al. J Hepatol. 2016 Dec;65(6):1140-1147. doi: 10.1016/j.jhep.2016.07.020. Epub 2016 Jul 25. J Hepatol. 2016. PMID: 27469901
BACKGROUND & AIMS: GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) is a prospective, observational registry study evaluating the safety of sorafenib and treatment practices in hepatocellular carcino …
BACKGROUND & AIMS: GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with so …
647 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page